Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Letrozole × CNS × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 59 Gynecologic 16 Thoracic 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Other 1 Head & Neck 1 Genitourinary 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 74 Magnetic Resonance Spectroscopy 65 Radiotherapy 42 Specimen Handling 41 Radiosurgery 29 Bevacizumab 28 Cyclophosphamide 26 pembrolizumab 20 Radiation 20 Blood Specimen Collection 18 Nivolumab 15 fludarabine 14 Irinotecan 14 Lomustine 13 Etoposide 12 Carboplatin 12 Vincristine 11 Pemetrexed 11 Biopsy 10 Surgical Procedures, Operative 9 Ipilimumab 9 lutetium Lu 177 dotatate 8 dinutuximab 8 abemaciclib 8 Fluorodeoxyglucose F18 8 trametinib 7 naxitamab 7 fluciclovine F-18 7 Proton Therapy 7 Magnetic Resonance Imaging 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2026-04-16

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡